Prof. Dr.med. Katarina Stingl

Head of the Center for Rare Eye Diseases, University of Tübingen, Germany

Prof. Dr.med. Katarina Stingl is Head of the Center for Rare Eye Diseases at the University of Tübingen, Germany.

Her research focuses on hereditary retinal degenerations, rare eye disease, retinal functional diagnostics, and electrophysiology of vision.

Disclosures

• PI of clinical trials funded by Foundation Fighting Blindness, ProQR Therapeutics, Janssen, Okuvision, ViGeneron, THEA.

• Is/has been consultant for Novartis, ProQR Therapeutics, ViGeneron, Santen, Janssen, Lundbeck, THEA, RhyGaze, with consultancy fees paid to Center for Ophthalmology, University of Tübingen to support research.

• European Reference Network for Rare Eye diseases: work group leader and HCP, coordinator for national activities.

• German Ophthalmological Society. Genetic section: speaker/leader.

• German Reference Network for Rare Eye diseases: national coordinator and HCP.

• Genetics section editor for the journal Klinische Monatsblätter für Augenheilkunde.

• Expert Committee member for Retinal Dystrophies in EVICR.net.

• Member of the Working Group Clinical Research PRO RETINA.